Stada and Mundipharma targeting iNova

Germany’s STADA Arzneimittel AG and Mundipharma International are among the bidders for Australia-based iNova, owned by Valeant group. The news was reported by the weekly Australian Financial Review, which also informed that GSK has apparently lost interest in an acquisition. In addition to Stada and Mundipharma, private equities KKR, The Carlyle Group and Pacific Equity Partners are reportedly seeking a deal.
(Source Australian Financial Review)